262 related articles for article (PubMed ID: 26265697)
1. GVHD-associated, inflammasome-mediated loss of function in adoptively transferred myeloid-derived suppressor cells.
Koehn BH; Apostolova P; Haverkamp JM; Miller JS; McCullar V; Tolar J; Munn DH; Murphy WJ; Brickey WJ; Serody JS; Gabrilovich DI; Bronte V; Murray PJ; Ting JP; Zeiser R; Blazar BR
Blood; 2015 Sep; 126(13):1621-8. PubMed ID: 26265697
[TBL] [Abstract][Full Text] [Related]
2. In vitro-generated MDSCs prevent murine GVHD by inducing type 2 T cells without disabling antitumor cytotoxicity.
Messmann JJ; Reisser T; Leithäuser F; Lutz MB; Debatin KM; Strauss G
Blood; 2015 Aug; 126(9):1138-48. PubMed ID: 26185131
[TBL] [Abstract][Full Text] [Related]
3. Danger-associated extracellular ATP counters MDSC therapeutic efficacy in acute GVHD.
Koehn BH; Saha A; McDonald-Hyman C; Loschi M; Thangavelu G; Ma L; Zaiken M; Dysthe J; Krepps W; Panthera J; Hippen K; Jameson SC; Miller JS; Cooper MA; Farady CJ; Iwawaki T; Ting JP; Serody JS; Murphy WJ; Hill GR; Murray PJ; Bronte V; Munn DH; Zeiser R; Blazar BR
Blood; 2019 Nov; 134(19):1670-1682. PubMed ID: 31533918
[TBL] [Abstract][Full Text] [Related]
4. Umbilical cord blood-derived mesenchymal stromal cells promote myeloid-derived suppressor cell proliferation by secreting HLA-G to reduce acute graft-versus-host disease after hematopoietic stem cell transplantation.
Yang S; Wei Y; Sun R; Lu W; Lv H; Xiao X; Cao Y; Jin X; Zhao M
Cytotherapy; 2020 Dec; 22(12):718-733. PubMed ID: 32811747
[TBL] [Abstract][Full Text] [Related]
5. Graft-Versus-Host Disease Prevention by
Scheurer J; Kitt K; Huber HJ; Fundel-Clemens K; Pflanz S; Debatin KM; Strauss G
Front Immunol; 2021; 12():754316. PubMed ID: 34721430
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13.
Highfill SL; Rodriguez PC; Zhou Q; Goetz CA; Koehn BH; Veenstra R; Taylor PA; Panoskaltsis-Mortari A; Serody JS; Munn DH; Tolar J; Ochoa AC; Blazar BR
Blood; 2010 Dec; 116(25):5738-47. PubMed ID: 20807889
[TBL] [Abstract][Full Text] [Related]
7. Ex Vivo Generated Human Cord Blood Myeloid-Derived Suppressor Cells Attenuate Murine Chronic Graft-versus-Host Diseases.
Lim JY; Ryu DB; Park MY; Lee SE; Park G; Kim TG; Min CK
Biol Blood Marrow Transplant; 2018 Dec; 24(12):2381-2396. PubMed ID: 30006304
[TBL] [Abstract][Full Text] [Related]
8. Development and function of myeloid-derived suppressor cells generated from mouse embryonic and hematopoietic stem cells.
Zhou Z; French DL; Ma G; Eisenstein S; Chen Y; Divino CM; Keller G; Chen SH; Pan PY
Stem Cells; 2010 Mar; 28(3):620-32. PubMed ID: 20073041
[TBL] [Abstract][Full Text] [Related]
9. Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia.
Fan Q; Liu H; Liang X; Yang T; Fan Z; Huang F; Ling Y; Liao X; Xuan L; Xu N; Xu X; Ye J; Liu Q
J Hematol Oncol; 2017 Jul; 10(1):135. PubMed ID: 28676100
[TBL] [Abstract][Full Text] [Related]
10. Dynamic change and impact of myeloid-derived suppressor cells in allogeneic bone marrow transplantation in mice.
Wang D; Yu Y; Haarberg K; Fu J; Kaosaard K; Nagaraj S; Anasetti C; Gabrilovich D; Yu XZ
Biol Blood Marrow Transplant; 2013 May; 19(5):692-702. PubMed ID: 23376089
[TBL] [Abstract][Full Text] [Related]
11. Graft monocytic myeloid-derived suppressor cell content predicts the risk of acute graft-versus-host disease after allogeneic transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood stem cells.
Vendramin A; Gimondi S; Bermema A; Longoni P; Rizzitano S; Corradini P; Carniti C
Biol Blood Marrow Transplant; 2014 Dec; 20(12):2049-55. PubMed ID: 25246295
[TBL] [Abstract][Full Text] [Related]
12. Extracorporeal photopheresis increases neutrophilic myeloid-derived suppressor cells in patients with GvHD.
Rieber N; Wecker I; Neri D; Fuchs K; Schäfer I; Brand A; Pfeiffer M; Lang P; Bethge W; Amon O; Handgretinger R; Hartl D
Bone Marrow Transplant; 2014 Apr; 49(4):545-52. PubMed ID: 24464140
[TBL] [Abstract][Full Text] [Related]
13. Suppression of proteoglycan-induced autoimmune arthritis by myeloid-derived suppressor cells generated in vitro from murine bone marrow.
Kurkó J; Vida A; Ocskó T; Tryniszewska B; Rauch TA; Glant TT; Szekanecz Z; Mikecz K
PLoS One; 2014; 9(11):e111815. PubMed ID: 25369029
[TBL] [Abstract][Full Text] [Related]
14. IDO1 scavenges reactive oxygen species in myeloid-derived suppressor cells to prevent graft-versus-host disease.
Ju JM; Nam G; Lee YK; Jung M; Chang H; Kim W; Shon WJ; Lim JY; Kim JY; Chang J; Min CK; Lee DS; Choi K; Shin DM; Choi EY
Proc Natl Acad Sci U S A; 2021 Mar; 118(10):. PubMed ID: 33649207
[TBL] [Abstract][Full Text] [Related]
15. The Role of Myeloid-Derived Suppressor Cells (MDSCs) in Graft-versus-Host Disease (GVHD).
Demosthenous C; Sakellari I; Douka V; Papayanni PG; Anagnostopoulos A; Gavriilaki E
J Clin Med; 2021 May; 10(10):. PubMed ID: 34064671
[TBL] [Abstract][Full Text] [Related]
16. The roles of sepsis-induced myeloid derived suppressor cells in mice corneal, skin and combined transplantation.
He Y; Bei J; Zeng H; Pan Z
Transpl Immunol; 2016 Feb; 34():8-13. PubMed ID: 26733333
[TBL] [Abstract][Full Text] [Related]
17. Early myeloid-derived suppressor cells (HLA-DR
Wang K; Lv M; Chang YJ; Zhao XY; Zhao XS; Zhang YY; Sun YQ; Wang ZD; Suo P; Zhou Y; Liu D; Zhai SZ; Hong Y; Wang Y; Zhang XH; Xu LP; Liu KY; Huang XJ
J Hematol Oncol; 2019 Mar; 12(1):31. PubMed ID: 30885244
[TBL] [Abstract][Full Text] [Related]
18. GM-CSF Promotes the Expansion and Differentiation of Cord Blood Myeloid-Derived Suppressor Cells, Which Attenuate Xenogeneic Graft-vs.-Host Disease.
Park MY; Lim BG; Kim SY; Sohn HJ; Kim S; Kim TG
Front Immunol; 2019; 10():183. PubMed ID: 30863394
[TBL] [Abstract][Full Text] [Related]
19. Bidirectional immune tolerance in nonmyeloablative MHC-mismatched BMT for murine β-thalassemia.
E S; Seth A; Vogel P; Sommers M; Ong T; Pillai AB
Blood; 2017 Jun; 129(22):3017-3030. PubMed ID: 28351935
[TBL] [Abstract][Full Text] [Related]
20. The inflammasome component NLRP3 impairs antitumor vaccine by enhancing the accumulation of tumor-associated myeloid-derived suppressor cells.
van Deventer HW; Burgents JE; Wu QP; Woodford RM; Brickey WJ; Allen IC; McElvania-Tekippe E; Serody JS; Ting JP
Cancer Res; 2010 Dec; 70(24):10161-9. PubMed ID: 21159638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
